Ataxin 7 like 3 pseudogene 1 (ATXN7L3P1)

ATXN7L3 pseudogene 1 (ATXN7L3P1) is classified as a processed pseudogene, related to the protein-coding gene ATXN7L3. Unlike protein-coding genes, pseudogenes such as ATXN7L3P1 typically contain disablements—mutations or truncations—that preclude protein translation. However, some processed pseudogenes are transcribed into RNA and may possess regulatory roles at the RNA level, though there is no direct evidence that ATXN7L3P1 acts as a regulatory RNA. Conservation and the presence of expressed sequence tags (ESTs) suggest it may be transcribed in some tissues, but no distinct protein, regulatory, or pathological function has been clearly defined for this pseudogene. ATXN7L3P1 should be distinguished from its parent gene ATXN7L3, a coactivator involved in transcriptional regulation and part of the SAGA complex, which has roles in epigenetic modification and has disease associations (such as spinocerebellar ataxia) in its protein-coding form. ATXN7L3P1 itself is not considered a therapeutic target and has no known interacting drugs or biomarker applications. Summary of relevance and limitations: - ATXN7L3P1 is not a therapeutic target (it is a pseudogene, not a receptor, enzyme, transporter, etc.). - No direct evidence for biological or disease roles; no known safety or biomarker roles. - No interacting drugs or known pharmaceutical mechanisms. - Its functional parent gene, ATXN7L3, participates in transcription regulation and chromatin modification, but these functions do not apply to the pseudogene.

Other names

ataxin 7 like 3 pseudogene 1ATXN7L3P1ataxin-7-like 3 pseudogene 1